U74389F, a 21-aminosteroid antioxidant, improves neoendothelial morphology, but not neointimal thickening after balloon catheter injury

Author： Murthy Subramanyam N.   Akers   Donald L.   Chen I-Li   Osgood   Thomas A.   Santiago Raphael   Fonseca Vivian A.   Kadowitz Philip J.   McNamara Dennis B.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.87, Iss.12, 2009-12, pp. : 1102-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of the 21-aminosteroid U74389F on ischemia-reperfusion injury in the rat

By Paroni R.   De Vecchi E.   Lubatti L.   Conti E.   Beretta C.   Rinaldi P.   Kienle M.G.   Trazzi R.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 737-742

Elsevier

Access to resources Recommend Favorite

Protection of Rat Heart from Ischaemia-Reperfusion Injury by the 21-Aminosteroid U-74389g

By Perna A.M.   Liguori P.   Bonacchi M.   Laino G.M.   Nediani C.   Fiorillo C.   Lunghi B.   Zecchi-Orlandini S.   Formigli L.   Ibba-Manneschi L.   Nassi P.  

Pharmacological Research, Vol. 34, Iss. 1, 1996-07 ,pp. : 25-31

Academic Press

Access to resources Recommend Favorite

The Effect of the Antioxidant Drug “U-74389G” on Oophoritis During Ischemia Reperfusion Injury in Rats

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 2, 2014-08 ,pp. : 103-107

Bentham Science Publishers

Access to resources Recommend Favorite

Early administration of YT-146, an adenosine A 2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury

By Takiguchi Y.   Nagano M.   Ikeda Y.   Nakashima M.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 205-207

Elsevier

Access to resources Recommend Favorite

A selective peroxisome proliferator-activated receptor-β/δ agonist attenuates neointimal hyperplasia after wire-mediated arterial injury

By Hamaya Rikuta  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1095-1106

Informa Healthcare

Access to resources Recommend Favorite